Patient internet use surrounding cancer clinical trials: clinician perceptions and responses.
Patient internet use surrounding cancer clinical trials: clinician perceptions and responses.
复制标题
围绕癌症临床试验的患者互联网使用情况：临床医生的看法和反应。
DOI：
10.1016/j.cct.2010.03.003
复制
发表时间：
2010
影响因子：
2.2
通讯作者：
Hillis,Stephen
中科院分区：
文献类型：
--
作者：
Simon,Christian;Schramm,Sarah;Hillis,Stephen
临床医生对与临床试验相关的患者互联网使用的看法没有得到很好的记录。这项探索性研究调查了 NCI 指定癌症中心的癌症护理提供者如何看待患者围绕癌症试验的互联网使用情况，包括它是否影响患者有关试验入组的决策。样本包括 20 名肿瘤科医生 (59%) 和 14 名护士 (41%) (n=34)。大多数临床医生（n=26；76%）认为互联网会影响患者是否决定参加癌症试验。三分之二（n=17；65%）认为这种效果是积极的，包括在增强患者对试验的了解、参与试验和参加试验方面。临床医生被问及是否曾与患者讨论过上网了解有关癌症试验的更多信息的话题。对此项目作出回应的人 (n=31) 中超过一半 (n=18; 58%) 表示“是”；其余（n=13；42%）表示不。大多数（n=10；77%）属于“否”类别的人都报告说互联网对患者的决策有影响。这些数据暂时表明，临床医生可能认为互联网对患者有关癌症试验的决策具有主要的积极影响，但他们与患者的沟通努力并不总是从逻辑上遵循这种看法。关于互联网使用的提供者与患者的讨论可能是临床医生为提高患者对癌症试验的了解和参与癌症试验做出贡献的机会。需要更多的研究来确认和解释临床医生对癌症患者与试验相关的互联网使用的看法和沟通之间的差距。
Clinician perceptions of patient internet use related to clinical trials are not well documented. This exploratory study surveyed how cancer care providers at one NCI-designated cancer center viewed patient internet use surrounding cancer trials, including whether it affected patient decision making regarding trial enrollment. The sample included 20 oncologists (59%) and 14 (41%) nurses (n=34). Most clinicians (n=26; 76%) perceived the internet as having an effect on whether or not patients decided to enroll in a cancer trial. Two thirds (n=17; 65%) felt that this effect was positive, including in terms of enhancing patient knowledge of, access to, and enrollment in trials. Clinicians were asked if they ever discussed with their patients the topic of going online to find out more about cancer trials. Over half (n=18; 58%) who responded (n=31) to this item said yes; the rest (n=13; 42%) said no. The majority (n=10; 77%) in the “no” category were among those who reported that the internet had an effect on patient decision making. These data provisionally suggest that clinicians may see the internet as having mostly a positive effect on patient decision making about cancer trials, but that their communication efforts with patients do not always logically follow from this perception. Provider–patient discussion about internet use may be an opportunity for clinicians to contribute to improved patient knowledge of and enrollment in cancer trials. More research is needed to confirm and explain the gap between clinician perception and communication regarding trial-related internet use by cancer patients.